-transparent.png){kind=logo}
Fluctuation of oligo-2',5'-adenylate synthetase (2-5AS) activity was examined in K562 cells infected with vaccine strains of measles virus (strains AIK-C and CAM-70) and mumps virus (strains Torii and Miyahara). Persistent infection was easily established in the mumps virus-infected cells without significant cytolysis or cell killing. In contrast, most of the cells infected with measles virus were killed by extensive cytolysis within 3 to 4 days. The small number of cells that did survive became persistently infected. That these persistently infected cells carried a virus antigen was confirmed by fluorescein isothiocyanate-labelled anti-measles virus rabbit antiserum and anti-mumps virus rabbit antiserum. The cells produced infectious progeny virus as well as interferon (IFN). Little induction of 2-5AS activity by IFN was demonstrated during the early stages of infection by these viruses. Similar results were observed in some of the persistently infected cells but not, however, K-CMP cells (K562 cells persistently infected with CAM-70) or K-MMP cells (K562 cells persistently infected with Miyahara). Failure to induce 2-5AS activity was unchanged in cells cultured for more than 6 months. The decrease of 2-5AS activity observed in K-MTP cells (K562 cells persistently infected with Torii) was the result of suppression of transcription of 2-5AS mRNA. On the other hand, a normal level of mRNA was found in K-AKP cells (K562 cells persistently infected with AIK-C). Therefore, it is suggested that the decrease of 2-5AS activity in K-AKP cells may be due to a failure to translate 2-5AS mRNA.
N Fujii, and
K Oguma, and
K Kimura, and
T Yamashita, and
S Ishida, and
K Fujinaga, and
T Yashiki
January 1983,
Archives of virology,
N Fujii, and
K Oguma, and
K Kimura, and
T Yamashita, and
S Ishida, and
K Fujinaga, and
T Yashiki
January 1991,
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
N Fujii, and
K Oguma, and
K Kimura, and
T Yamashita, and
S Ishida, and
K Fujinaga, and
T Yashiki
November 1980,
Biochemical and biophysical research communications,
N Fujii, and
K Oguma, and
K Kimura, and
T Yamashita, and
S Ishida, and
K Fujinaga, and
T Yashiki
September 1979,
Journal of virology,
N Fujii, and
K Oguma, and
K Kimura, and
T Yamashita, and
S Ishida, and
K Fujinaga, and
T Yashiki
June 1985,
Gut,
N Fujii, and
K Oguma, and
K Kimura, and
T Yamashita, and
S Ishida, and
K Fujinaga, and
T Yashiki
February 1983,
European journal of biochemistry,
N Fujii, and
K Oguma, and
K Kimura, and
T Yamashita, and
S Ishida, and
K Fujinaga, and
T Yashiki
December 1984,
Journal of clinical microbiology,
N Fujii, and
K Oguma, and
K Kimura, and
T Yamashita, and
S Ishida, and
K Fujinaga, and
T Yashiki
October 1987,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
N Fujii, and
K Oguma, and
K Kimura, and
T Yamashita, and
S Ishida, and
K Fujinaga, and
T Yashiki
March 1980,
Journal of virology,
N Fujii, and
K Oguma, and
K Kimura, and
T Yamashita, and
S Ishida, and
K Fujinaga, and
T Yashiki
January 1985,
Archives of virology,
